LATENT TUBERCULOSIS
Clinical trials for LATENT TUBERCULOSIS explained in plain language.
Never miss a new study
Get alerted when new LATENT TUBERCULOSIS trials appear
Sign up with your email to follow new studies for LATENT TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cash and cameras: new study fights TB by boosting treatment completion
Disease control Recruiting nowThis study tests whether offering small financial rewards and using video calls to watch people take their medicine can help more people finish treatment for latent tuberculosis. About 399 adults in Baltimore who are starting TB treatment will be split into groups: some get usual…
Matched conditions: LATENT TUBERCULOSIS
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 12, 2026 12:05 UTC
-
One-Month TB shield: Game-Changer for teens?
Prevention Recruiting nowThis study tests a new, ultra-short 1-month treatment to prevent tuberculosis (TB) in teenagers and school staff who have been exposed to someone with active TB. The goal is to see if the 1-month regimen is as effective as the standard 3-month treatment, while being easier to com…
Matched conditions: LATENT TUBERCULOSIS
Phase: PHASE3 • Sponsor: Huashan Hospital • Aim: Prevention
Last updated Jun 16, 2026 23:49 UTC
-
TB prevention breakthrough? 6-Week regimen could replace months of treatment
Prevention Recruiting nowThis study compares a new 6-week daily rifapentine regimen to the standard 12-16 week rifamycin-based treatment for latent tuberculosis infection (LTBI). The goal is to see if the shorter treatment is just as safe and effective at preventing active TB. About 3,400 people at highe…
Matched conditions: LATENT TUBERCULOSIS
Phase: PHASE2, PHASE3 • Sponsor: Centers for Disease Control and Prevention • Aim: Prevention
Last updated Jun 08, 2026 13:07 UTC
-
TB study seeks volunteers to help scientists uncover disease secrets
Knowledge-focused Recruiting nowThis study aims to learn more about tuberculosis (TB) by collecting blood, sputum, and skin samples from people with active or latent TB. Researchers will follow participants over time to track how the disease progresses and how the body responds. The goal is to improve understan…
Matched conditions: LATENT TUBERCULOSIS
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:25 UTC